Skip to content

Addiction: all studies

Page 304 of 857: studies 3,031 to 3,040 of 8,563, newest first. Back to the addiction overview

Research

The effects of mindfulness meditation combined with happiness therapy on the psychological status and survival of patients with middle and advanced non-small cell lung cancer

Psycho-Oncologie March 6, 2025 Yang Yu, Enhui Liu, Juan Zhou et al.

Objective: The study aimed to investigate the effectiveness of the intervention on psychological resilience, negative emotions, and overall well-being of subjects with non-small cell lung cancer (NSCLC) in middle and advanced stages utilizing happiness therapy combined with positive thinking-meditation expected to provide a basis for clinical psychological intervention. Methods: One hundred...

Educational moderation of gender disparities in psychedelic health outcomes

Academia Mental Health and Well-Being March 6, 2025 S. Viña

While public interest in psychedelics is rising due to their potential effects on mental health, evidence suggests that these associations vary across demographic groups. Notably, prior research indicates that women may experience different outcomes from psychedelic use compared to men. Given that highly educated women tend to have superior health outcomes in general, this study examines...

Psychedelic iatrogenic structural dissociation: an exploratory hypothesis on dissociative risks in psychedelic use.

Frontiers in Psychology March 4, 2025 Steven Elfrink, Leigh Bergin 11 citations

This paper introduces the hypothesis of Psychedelic Iatrogenic Structural Dissociation (PISD), proposing that psychedelics may reactivate dissociated traumatic material, increasing the risk of psychological destabilization in trauma-exposed individuals. Grounded in structural dissociation theory, this framework suggests that psychedelics can disrupt the balance between daily functioning (the...

Psilocybin therapy might help frontline pandemic workers

The Brown University Psychopharmacology Update March 3, 2025

The stressors that frontline healthcare workers experienced during the COVID-19 pandemic led to widespread burnout, depression, and post-traumatic stress disorder (PTSD). Based on research showing that psychedelic-assisted therapy led to improvement in symptoms of depression in various populations, investigators conducted a randomized clinical trial to evaluate the effects of psilocybin therapy...

Mortality risk among people receiving acute hospital care for hallucinogen use compared with the general population.

Canadian Medical Association Journal March 2, 2025 Daniel T. Myran, Jennifer Xiao, Nicholas Fabiano et al. 8 citations

Background: Although clinical trials involving psychedelic-assisted psychotherapy have not observed short-term increases in the risk of death, limited data exist on mortality associated with hallucinogen use outside of controlled trial settings. We sought to determine whether people with an emergency department visit or hospital admission involving hallucinogen use were at increased risk of...

DOI: 10.1503/cmaj.241191 (opens in new tab) Full text (opens in new tab) Hallucinogen use Psychedelic use Substance use Drug use +21

Lysergic psychoma and mental automatism: a clinical exploration of synthetic psychosis.

Rivista di psichiatria March 1, 2025 Alessandro Sarni, Giovanni Martinotti, Giuseppe Maina et al.

The increasing prevalence of Novel Psychoactive Substances (NPS) presents a significant challenge for both diagnosis and treatment, particularly due to the complex psychotic states they can induce. This paper explores the concept of lysergic psychoma, rooted in Bonhoeffer's exogenous psychosis model, and its relevance to modern substance-induced psychoses. Lysergic psychoma, characterized by...

Surface code model for Fibonacci helical pathways of the Orch OR microtubule.

Biosystems March 1, 2025 Seungju An, Byung-Soo Choi

The Objective Reduction (OR) theory suggested by Sir Roger Penrose presented a novel perspective on the measurement problem of quantum mechanics and consciousness. Subsequently, based on the assertion of anesthesiologist Dr. Hameroff, the theory proposed that the phenomenon of OR could also manifest in microtubules within neurons. This would, serve as the trigger for consciousness, thereby...

DOI: 10.1016/j.biosystems.2025.105414 (opens in new tab) Full text (opens in new tab) Consciousness Helical pathway Microtubule Objective reduction +4

Alterations in temporal-spatial brain entropy in treatment-resistant depression treated with nitrous oxide: Evidence from resting-state EEG.

Clinical Neurophysiology March 1, 2025 Weizhuang Kong, Zhe Sun, Jing Zhu et al.

Entropy analysis can quantify the dynamic states of the brain and reflect its information processing capacity. Nitrous oxide has shown rapid antidepressant effects in treatment-resistant depression (TRD) patients, but its biomarkers are not yet established. We recruited 44 TRD patients and randomly assigned them to two groups: one received a 1-hour nitrous oxide inhalation treatment, while the...

DOI: 10.1016/j.clinph.2025.01.014 (opens in new tab) Full text (opens in new tab) Multivariate multiscale entropy Nitrous oxide Resting-State EEG Temporal-spatial brain entropy +1

Do undergraduates’ views of psychedelics relate to the context for psychedelic use?

Drug Science, Policy and Law March 1, 2025 Dan Petrovitch, Jason van Allen, Sean M. Mitchell et al. 1 citation

Psychedelic drug policy is changing, both in the USA and internationally. However, psychedelic use is not homogeneous, as there are multiple unique contexts for use, including clinical therapies, naturalistic use, and microdosing. There are notable differences between these contexts regarding emerging evidence for safety, therapeutic efficacy, likely future legality, and more. We compared...

The Selective 5HT2A Receptor Agonist, 25CN-NBOH Exerts Excitatory and Inhibitory Cellular Actions on Mouse Medial Prefrontal Cortical Neurons.

Synapse March 1, 2025 Yang Wang, Jesper L. Kristensen, Kristi A. Kohlmeier 5 citations

Psychedelic compounds have gained renewed interest due to their rapid and long-lasting therapeutic effects on stress-related disorders. While the underlying mechanisms of therapeutic actions of psychedelic compounds are still unclear, these drugs are thought to modulate the activity of the serotonergic system, primarily through activating serotonin type 2A receptor (5-HT2AR) and studies have...

DOI: 10.1002/syn.70014 (opens in new tab) Full text (opens in new tab) Serotonin Action potential Brain slices Electrophysiological recordings +1